TITLE

Duodenal Somatostatinoma Presenting as Upper Gastrointestinal Bleeding

AUTHOR(S)
Saifuddin, Tahira; Linder, Chadwick; Banerjee, Bhaskar
PUB. DATE
May 1999
SOURCE
American Journal of Gastroenterology;May1999, Vol. 94 Issue 5, p1405
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Duodenal somatostatinoma is a rare cause of upper gastrointestinal bleeding. We report the case of a 55-yr-old woman who presented with upper gastrointestinal hemorrhage due to a duodenal somatostatinoma. We discuss the characteristics of these tumors, and review the literature on diagnostic workup and management.
ACCESSION #
16070930

 

Related Articles

  • [sup 99m]Tc-Demotate 1: first data in tumour patients—results of a pilot/phase I study. Decristoforo, Clemens; Mama, Theodosia; Nock, Berthold; Gabriel, Michael; Cordopatis, Paul; Moncayo, Roy // European Journal of Nuclear Medicine & Molecular Imaging;2003, Vol. 30 Issue 9, p1211 

    Abstract Somatostatin receptor (SSTR) scintigraphy with indium-111 DTPA-octreotide has become a routine diagnostic procedure in oncology. However, it suffers some drawbacks concerning the limited availability, sub-optimal imaging properties and elevated radiation burden of "In. We have recently...

  • Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [Lu-DOTA,Tyr]octreotate. Keizer, Bart; Aken, Maarten; Feelders, Richard; Herder, Wouter; Kam, Boen; Essen, Martijn; Krenning, Eric; Kwekkeboom, Dik // European Journal of Nuclear Medicine & Molecular Imaging;Apr2008, Vol. 35 Issue 4, p749 

    Introduction: Receptor radionuclide therapy is a promising treatment modality for patients with neuroendocrine tumors for whom alternative treatments are limited. The aim of this study was to investigate the incidence of hormonal crises after therapy with the radiolabeled somatostatin analogue...

  • [sup 86] Y-DOTA[sup 0] -d-Phe[sup 1] -Tyr[sup 3] -octreotide (SMT487)–a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion. Jamar, François; Barone, Raffaella; Mathieu, Isabelle; Walrand, Stéphan; Labar, Daniel; Carlier, Pascal; De Camps, Joëlle; Schran, Horst; Chen, TianLing; Smith, M. Charles; Bouterfa, Hakim; Valkema, Roelf; Krenning, Eric P.; Kvols, Larry K.; Pauwels, Stanislas // European Journal of Nuclear Medicine & Molecular Imaging;2003, Vol. 30 Issue 4, p510 

    Evaluates the pharmacokinetics and dosimetry of [sup 86]Y-DOTA[sup 0]-D-Phe[sup 1]-Tyr[sup 3]-octreotide in a phase I positron emission tomography study of patients with somatostatin receptor-positive neuroendocrine tumors. Effect of amino acid co-infusion on renal and tumor uptake; Suggestion...

  • Endoscopic Treatment of Dieulafoy's Lesion of the Duodenum. Goldenberg, Steven P.; DeLuca Jr., Vincent A.; Marignani, Pierluigi // American Journal of Gastroenterology;Apr1990, Vol. 85 Issue 4, p452 

    Dieulafoy's lesion is an often unrecognized cause of catastrophic upper gastrointestinal hemorrhage, typically seen in otherwise asymptomatic patients. Although the lesion is most often found in the stomach, it has rarely been reported to occur in the jejunum and duodenum. Endoscopic treatment...

  • Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 ‘clinically aggressive’ cases. Righi, L.; Volante, M.; Tavaglione, V.; Billè, A.; Daniele, L.; Angusti, T.; Inzani, F.; Pelosi, G.; Rindi, G.; Papotti, M. // Annals of Oncology;Mar2010, Vol. 21 Issue 3, p548 

    Background: The management of pulmonary neuroendocrine tumours (NETs), with special reference to clinically aggressive carcinoids and large-cell neuroendocrine carcinomas (LCNECs), is poorly standardised and data about somatostatin receptor (SSTR) expression or therapeutic guidelines for...

  • 543. Monitoring Transgene Expression by Radio-Peptide Positron Emission Tomography. Gazdhar, Amiq; Bilici, Murat; Ayuni, Erick; Krause, Thomas; Hofmann, Michal; Schmid, Raplh A. // Molecular Therapy;Jun2006, Vol. 13, pS209 

    Background Progress towards Clinical application of gene therapy is hindered by the lack of possibility to image and trace transgene expression. Optical methods using fluorescent gene products or chemiluminesce inducing enzymes are not fully quantitative because of tissue absorption and...

  • 543. Monitoring Transgene Expression by Radio-Peptide Positron Emission Tomography. Gazdhar, Amiq; Bilici, Murat; Ayuni, Erick; Krause, Thomas; Hofmann, Michal; Schmid, Raplh A. // Molecular Therapy;Jun2006, Vol. 13, pS209 

    Background Progress towards Clinical application of gene therapy is hindered by the lack of possibility to image and trace transgene expression. Optical methods using fluorescent gene products or chemiluminesce inducing enzymes are not fully quantitative because of tissue absorption and...

  • Biokinetics and dosimetry in patients administered with [sup 111] In-DOTA-Tyr[sup 3] -octreotide: implications for internal radiotherapy with [sup 90] Y-DOTATOC. Cremonesi, Marta; Ferrari, Mahila; Zoboli, Stefania; Chinol, Marco; Stabin, Michael G.; Orsi, Franco; Maecke, Helmut R.; Jermann, Eduard; Robertson, Christopher; Fiorenza, Maurizio; Tosi, Giampiero; Paganelli, Giovanni // European Journal of Nuclear Medicine;1999, Vol. 26 Issue 8, p877 

    Abstract. Recent advances in receptor-mediated tumour imaging have resulted in the development of a new somatostatin analogue, DOTA-DPhe[sup 1]-Tyr[sup 3]-octreotide. This new compound, named DOTATOC, has shown high affinity for somatostatin receptors, ease of labelling and stability with...

  • Biokinetics and imaging with the somatostatin receptor PET radioligand [sup 68] Ga-DOTATOC: preliminary data. Hofmann, M.; Maecke, H.; Börner, R.; Weckesser, E.; Schöffski, P.; Oei, L.; Schumacher, J.; Henze, M.; Heppeler, A.; Meyer, J.; Knapp, H. // European Journal of Nuclear Medicine;2001, Vol. 28 Issue 12, p1751 

    Somatostatin (SMS) scintigraphy is widely used for the detection and staging of neuroendocrine tumours. Because of its superior imaging properties, there is growing interest in the use of positron emission tomography (PET) technology for SMS scintigraphy. This study addressed the production of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics